INNOGENE Co.,Ltd. (KOSDAQ:344860)
South Korea · Delayed Price · Currency is KRW 1,526.00
+140.00 (10.10%)
At close: May 20, 2026
INNOGENE Revenue
In the year 2025, INNOGENE had annual revenue of 8.21B KRW, down -8.17%. INNOGENE had revenue of 2.41B in the quarter ending December 31, 2025, with 17.50% growth.
Revenue
8.21B
Revenue Growth
-8.17%
P/S Ratio
2.24
Revenue / Employee
n/a
Employees
n/a
Market Cap
18.36B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 8.21B | -731.15M | -8.17% |
| Dec 31, 2024 | 8.94B | -1.16B | -11.45% |
| Dec 31, 2023 | 10.10B | 961.65M | 10.52% |
| Dec 31, 2022 | 9.14B | -245.63M | -2.62% |
| Dec 31, 2021 | 9.39B | 3.74B | 66.29% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Organic Tea Cosmetics Holdings Company | 183.29B |
| Medience | 48.77B |
| Bonne | 46.01B |
| Outin Futures | 42.39B |
| Sewha P&C INC. | 37.65B |
| Csa Cosmic | 27.93B |
| Nord Mason | 21.26B |
| KMPHARMACEUTICAL | 15.99B |